Fluoxetine Treatment of Depression in Down Syndrome
Status:
Not yet recruiting
Trial end date:
2027-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to do a preliminary assessment of whether fluoxetine is
effective, safe, and tolerable for the treatment of depression in adults with Down syndrome.